Although the long-term outlook is a bit hazy for the medical-device sector, at least the nearer future should become a little more clear next week when Johnson & Johnson, St. Jude Medical and Abbott Laboratories report their quarterly results.

The Street (http://www.thestreet.com/_googlen/stocks/biotech/10262806.html?cm_ven=GOOGLEN&cm_cat=FREE&cm_ite=NA)